- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Glabellar Crease in United Kingdom
Total 7463 results
-
Hope Rugo, MDUniversity of California, San Francisco; AmgenTerminatedEarly Stage Breast CancerUnited States
-
Duke UniversityNational Comprehensive Cancer NetworkWithdrawnBreast Cancer Triple NegativeUnited States
-
Duke UniversityUnited States Department of DefenseTerminatedEarly-Stage Breast CancerUnited States
-
Jonsson Comprehensive Cancer CenterSusan G. Komen Breast Cancer FoundationCompletedYounger Breast Cancer SurvivorsUnited States
-
Icahn School of Medicine at Mount SinaiNational Cancer Institute (NCI)Completed
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingRecurrent Breast Inflammatory Carcinoma | Stage IV Breast Inflammatory CarcinomaUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLCUnknownStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Stage III Breast CancerUnited States
-
Washington University School of MedicineNational Institute on Minority Health and Health Disparities (NIMHD)CompletedOncology | Breast Cancer Screening | Mammography | Preventative MedicineUnited States
-
Wake Forest University Health SciencesCompletedBreast Cancer | Breast Reconstruction | CosmesisUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedLymphedema | Stage II Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Recurrent Breast CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI); National Institute of Nursing Research (NINR)CompletedDuctal Breast Carcinoma in Situ | BRCA1 Mutation Carrier | BRCA2 Mutation Carrier | Atypical Ductal Breast Hyperplasia | Lobular Breast Carcinoma in Situ | Atypical Lobular Breast HyperplasiaUnited States
-
Washington University School of MedicineNovartis; National Comprehensive Cancer NetworkNot yet recruitingBreast Cancer | Cancer of the BreastUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)Recruiting
-
Hope Rugo, MDGlaxoSmithKlineCompletedBreast Cancer | Breast NeoplasmUnited States
-
Roswell Park Cancer InstituteAstraZeneca; National Center for Complementary and Integrative Health (NCCIH)Completed
-
University of MichiganNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedBreast CancersUnited States
-
OncoSec Medical IncorporatedCompletedER-Negative PR-Negative HER2-Negative Breast CancerUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)RecruitingAnatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage 0 Breast Cancer AJCC v8 | Localized Breast CarcinomaUnited States
-
University of Texas Southwestern Medical CenterCancer Prevention Research Institute of TexasCompletedBreast Cancer FemaleUnited States
-
Taiho Oncology, Inc.CompletedAdvanced Solid Tumors (Excluding Breast Cancer)United States
-
Queen Mary University of LondonAstraZenecaCompletedEstrogen Receptor Positive Breast CancerSpain, United Kingdom, France, Portugal, Georgia, Korea, Republic of, Germany, Hungary, Romania
-
MedSIRStemline Therapeutics, Inc.RecruitingAdvanced Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast Cancer | ESR1 Gene MutationSpain, Austria, France, Germany, Greece, United Kingdom, Czechia, Italy, Brazil
-
Dana-Farber Cancer InstituteGenentech, Inc.Active, not recruitingBreast Cancer | Stage II Breast Cancer | HER-2 Positive Breast Cancer | Stage III Breast CancerUnited States
-
University of PittsburghRecruitingTriple Negative Breast CancerUnited States
-
M.D. Anderson Cancer CenterArtidisRecruitingBreast Carcinoma | Invasive Breast CarcinomaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Private Philanthropic FundsRecruiting
-
H. Lee Moffitt Cancer Center and Research InstituteVaccinex Inc.RecruitingHER2-positive Breast CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteImmunoRestorationRecruitingHER2-positive Breast CancerUnited States
-
University of MiamiRecruitingBreast Cancer | Early-stage Breast CancerUnited States
-
University of WashingtonTerminatedHER2-positive Breast CancerUnited States
-
Medical College of WisconsinCompletedNode Positive Breast CancerUnited States
-
University of Alabama at BirminghamWithdrawnHER2-positive Breast CancerUnited States
-
Daiichi SankyoCompletedHER2-positive Breast CancerUnited States
-
Case Comprehensive Cancer CenterWithdrawnHR-positive Breast CancerUnited States
-
Hoag Memorial Hospital PresbyterianRayzeBio, Inc.Active, not recruiting
-
Emory UniversityTerminatedBreast Cancer | Breast Neoplasms | Cancer of the BreastUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; GlaxoSmithKline; Brigham and Women's Hospital; North...CompletedBreast Cancer | Stage IV Breast CancerUnited States
-
University of Wisconsin, MadisonCompletedBreast Cancer | Triple Negative Breast CancerUnited States
-
Hoffmann-La RocheCompletedBreast Cancer, Colorectal CancerNew Zealand, Australia, United Kingdom
-
St. Joseph Hospital of OrangeCompletedStage 0 Breast Carcinoma | Stage I Breast Carcinoma | Stage II Breast Carcinoma | Invasive Ductal and Invasive Lobular Breast CarcinomaUnited States
-
Roswell Park Cancer InstituteWithdrawnAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast Carcinoma | Unresectable Triple-Negative Breast CarcinomaUnited States
-
Ohio State University Comprehensive Cancer CenterCompletedPeripheral Neuropathy | Stage I Breast Cancer AJCC v7 | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7United States
-
Cedars-Sinai Medical CenterSummit TherapeuticsRecruitingTNBC - Triple-Negative Breast Cancer | TNBC | Early Stage Triple-Negative Breast CarcinomaUnited States
-
Thomas Jefferson UniversityNational Cancer Institute (NCI)Active, not recruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 and other conditionsUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)RecruitingMetastatic Triple-Negative Breast Carcinoma | Metastatic HER2-Negative Breast CarcinomaUnited States
-
Mylin A. Torres, MDPfizer; Genentech, Inc.; Emory UniversityTerminatedBreast Cancer | Triple Negative Breast CancerUnited States
-
George Washington UniversityWithdrawnTriple Negative Breast CancerUnited States
-
Dana-Farber Cancer InstituteCompleted